Download

Full Text

• Al-Eryani L, Wahlang B, Falkner KC et al (2015) Identification of environmental chemicals associated with the development of toxicant-associated fatty liver disease in rodents. Toxicol Pathol 43(4):482–497 DOI: 10.1177/0192623314549960
• Bal-Price A, Meek MEB (2017) Adverse outcome pathways: application to enhance mechanistic understanding of neurotoxicity. Pharmacol Ther 179:84–95 DOI: 10.1016/j.pharmthera.2017.05.006
• Barnett LMA, Cummings BS (2019) Cellular and molecular mechanisms of kidney toxicity. Semin Nephrol 39(2):141–151 DOI: 10.1016/j.semnephrol.2018.12.004
• Boone L, Meyer D, Cusick P et al (2005) Selection and interpretation of clinical pathology indicators of hepatic injury in preclinical studies. Vet Clin Pathol 34(3):182–188 DOI: 10.1111/j.1939-165X.2005.tb00041.x
• Broadway-Duren JB, Klaassen H (2013) Anemias. Crit Care Nurs Clin N Am 25(4):411–426 DOI: 10.1016/j.ccell.2013.09.004
• Cascio MJ, DeLoughery TG (2017) Anemia: evaluation and diagnostic tests. Med Clin N Am 101(2):263–284 DOI: 10.1016/j.mcna.2016.09.003
• Cattley RC, Cullen JM (2013) Chapter 45—liver and gall bladder. In: Haschek CGR, Wallig MA (eds) Haschek and Rousseaux's handbook of toxicologic pathology, 3rd edn. Academic Press, Cambridge, pp 1509–1566 DOI: 10.1016/B978-0-12-415759-0.00045-5
• Daneshian M, Kamp H, Hengstler J et al (2016) Highlight report: launch of a large integrated European in vitro toxicology project: EU-ToxRisk. Arch Toxicol 90(5):1021–1024 DOI: 10.1007/s00204-016-1698-7
• David S, Hamilton JP (2010) Drug-induced liver injury. US Gastroenterol Hepatol Rev 6:73–80
• Dent M, Teixeira Amaral R, Amores Da Silva P et al (2018) Principles underpinning the use of new methodologies in the risk assessment of cosmetic ingredients. Comput Toxicol 7:20–26 DOI: 10.1016/j.comtox.2018.06.001
• Desprez B, Dent M, Keller D et al (2018) A strategy for systemic toxicity assessment based on non-animal approaches: the cosmetics europe long range science strategy programme. Toxicol Vitro 50:137–146 DOI: 10.1016/j.tiv.2018.02.017
• EU (1976) Council Directive 76/768/EEC of 27 July 1976 on the approximation of the laws of the member states relating to cosmetic products. OV J L 262:169–200
• EU (2003) Directive 2003/15/EC of the European Parliament and of the Council of 27 February 2003 amending Council Directive 76/768/EEC on the approximation of the laws of the Member States relating to cosmetic products. 66 OL
• EU (2008) Commission decision 2008/721/EC of 5 September 2008 setting up an advisory structure of scientific committees and experts in the field of consumer safety, public health and the environment and repealing decision 2004/210/EC. Off J L 241:21–30
• EU (2009) Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products. Off J L. 342, 22.12.2009, p 59–209
• Gocht T, Berggren E, Ahr HJ et al (2015) The SEURAT-1 approach towards animal free human safety assessment. Altex 32(1):9–24 DOI: 10.14573/altex.1408041
• Greim H, Snyder R (2008) Toxicology and risk assessment: a comprehensive introduction. Wiley, Chichester DOI: 10.1002/9780470868959
• Grimes CN, Fry MM (2015) Nonregenerative anemia: mechanisms of decreased or ineffective erythropoiesis. Vet Pathol 52(2):298–311 DOI: 10.1177/0300985814529315
• Hall AP, Elcombe CR, Foster JR et al (2012) Liver hypertrophy: a review of adaptive (adverse and non-adverse) changes–conclusions from the 3rd International ESTP Expert Workshop. Toxicol Pathol 40(7):971–994 DOI: 10.1177/0192623312448935
• Hayes AW, Kruger CL (2014) Hayes' principles and methods of toxicology, 6th edn. CRC Press, Boca Raton DOI: 10.1201/b17359
• Ipsen DH, Lykkesfeldt J, Tveden-Nyborg P (2018) Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease. Cell Mol Life Sci 75(18):3313–3327 DOI: 10.1007/s00018-018-2860-6
• Kim CH (2010) Homeostatic and pathogenic extramedullary hematopoiesis. J Blood Med 1:13–19 DOI: 10.2147/JBM.S7224
• Kroes R, Renwick AG, Feron V et al (2007) Application of the threshold of toxicological concern (TTC) to the safety evaluation of cosmetic ingredients. Food Chem Toxicol 45(12):2533–2562 DOI: 10.1016/j.fct.2007.06.021
• Laroche C, Annys E, Bender H et al (2019) Finding synergies for the 3Rs—repeated dose toxicity testing: report from an EPAA Partners' Forum. Regul Toxicol Pharmacol 108:104470 DOI: 10.1016/j.yrtph.2019.104470
• Lee WM (2013) Drug-induced acute liver failure. Clin Liver Dis 17(4):575–586 DOI: 10.1016/j.cld.2013.07.001
• Mebius RE, Kraal G (2005) Structure and function of the spleen. Nat Rev Immunol 5(8):606–616 DOI: 10.1038/nri1669
• Michael B, Yano B, Sellers RS et al (2007) Evaluation of organ weights for rodent and non-rodent toxicity studies: a review of regulatory guidelines and a survey of current practices. Toxicol Pathol 35(5):742–750 DOI: 10.1080/01926230701595292
• OECD (2018) Test No. 408: repeated dose 90-day oral toxicity study in rodents, OECD guidelines for the testing of chemicals, section 4. OECD Publishing, Paris
• Onakpoya IJ, Heneghan CJ, Aronson JK (2019) Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature. BMC Med 14:10 (published correction appears in BMC Med. 2019 Mar 2;17(1):56) DOI: 10.1186/s12916-016-0553-2
• Robles-Diaz M, Garcia-Cortes M, Medina-Caliz I et al (2015) The value of serum aspartate aminotransferase and gamma-glutamyl transpetidase as biomarkers in hepatotoxicity. Liver Int 35(11):2474–2482 DOI: 10.1111/liv.12834
• Rogiers V, Benfenati E, Bernauer U et al (2020) The way forward for assessing the human health safety of cosmetics in the EU—workshop proceedings. Toxicology 436:152421 DOI: 10.1016/j.tox.2020.152421
• SCCS (Scientific Committee on Consumer Safety) (2009) Opinion on HC Red n° 7. 8 December 2009 SCCS/1229/09
• SCCS (Scientific Committee on Consumer Safety) (2010a) Opinion on 2,7-Naphthalenediol. 21 September 2010 SCCS/1366/10
• SCCS (Scientific Committee on Consumer Safety) (2010b) Opinion on sodium perborate and perboric acid. 22 June 2010 SCCS/1345/10
• SCCS (Scientific Committee on Consumer Safety) (2011) Opinion on Basic Red 51. 22 March 2011 SCCS/1332/10
• SCCS (Scientific Committee on Consumer Safety) (2018) The SCCS notes of guidance for the testing of cosmetic ingredients and their safety evaluation, 10th revision, SCCS/1602/18.
• Vilas-Boas V, Gijbels E, Cooreman A et al (2019) Industrial, biocide, and cosmetic chemical inducers of cholestasis. Chem Res Toxicol 32(7):1327–1334 DOI: 10.1021/acs.chemrestox.9b00148
• Vinken M, Pauwels M, Ates G et al (2012) Screening of repeated dose toxicity data present in SCC(NF)P/SCCS safety evaluations of cosmetic ingredients. Arch Toxicol 86(3):405–412 DOI: 10.1007/s00204-011-0769-z
• Vinken M (2020) 3Rs toxicity testing and disease modelling projects in the European Horizon 2020 research and innovation program. EXCLI J 19:775–784